Business Context and Reporting Period
This Form 8-K filing by Becton, Dickinson and Company (BD) reports a material event occurring on December 4, 2014, with the report filed on December 9, 2014. The filing details the execution of an underwriting agreement to raise capital specifically to finance the acquisition of CareFusion Corporation.
Key Financial Metrics and Capital Structure
The Company entered into an agreement to sell a total of $6.2 billion in debt securities. The specific tranches include:
- $750 million aggregate principal amount of Floating Rate Notes due 2016.
- $1.25 billion aggregate principal amount of 1.800% Senior Notes due 2017.
- $1.25 billion aggregate principal amount of 2.675% Senior Notes due 2019.
- $1.75 billion aggregate principal amount of 3.734% Senior Notes due 2024.
- $1.20 billion aggregate principal amount of 4.685% Senior Notes due 2044.
The net proceeds from this offering, combined with borrowings under the commercial paper program, a new term loan facility, and existing cash on hand, are designated to fund the CareFusion acquisition and associated fees. This filing does not provide specific revenue, profit, cash flow, or margin data for the reporting period.
Material Changes and Outlook
The primary material change is the significant increase in debt obligations to facilitate a major strategic acquisition. Management expects the offering to be completed on or about December 15, 2014, subject to customary closing conditions. The filing does not contain specific forward-looking guidance on earnings or operational metrics, nor does it detail specific risks beyond the standard closing conditions for the debt offering.
Investor Verification Checklist
- Verify the final closing date of the $6.2 billion debt offering (expected December 15, 2014).
- Confirm the final terms of the new term loan facility mentioned as part of the funding mix.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) for covenants and conditions.
- Monitor subsequent filings for the completion status of the CareFusion Corporation acquisition.